0,673  0,020  CYP3A4 substrate
0,673  0,024  Antineoplastic (breast cancer)
0,607  0,010  Nootropic
0,600  0,016  Antineoplastic (ovarian cancer)
0,567  0,007  Antineoplastic (lymphoma)
0,576  0,026  Antineoplastic (colorectal cancer)
0,575  0,024  Antineoplastic (colon cancer)
0,551  0,004  Interleukin 6 antagonist
0,540  0,023  Cognition disorders treatment
0,532  0,017  Antiosteoporotic
0,531  0,022  Bone diseases treatment
0,486  0,024  Antineoplastic (cervical cancer)
0,483  0,040  CYP2C9 substrate
0,480  0,048  Antineoplastic (lung cancer)
0,431  0,011  Contraceptive
0,416  0,003  Progesterone antagonist
0,410  0,009  Antiviral (Influenza)
0,480  0,081  Apoptosis agonist
0,458  0,065  Alzheimer's disease treatment
0,400  0,017  Sodium/bile acid cotransporter inhibitor
0,388  0,007  Acetylcholinesterase inhibitor
0,459  0,078  Caspase 9 stimulant
0,401  0,025  Nitric oxide antagonist
0,417  0,041  Respiratory analeptic
0,386  0,010  Cholinergic
0,398  0,025  UGT1A6 substrate
0,385  0,013  UGT2B7 substrate
0,395  0,023  Potassium channel blocker
0,378  0,010  Lipocortins synthesis antagonist
0,393  0,026  Antihypoxic
0,373  0,019  UGT1A4 substrate
0,371  0,026  Antineoplastic (endocrine cancer)
0,378  0,036  UGT2B4 substrate
0,382  0,044  NOS3 expression inhibitor
0,347  0,023  UGT1A1 substrate
0,369  0,046  CYP2C19 substrate
0,337  0,015  Prostate disorders treatment
0,325  0,008  Antifungal enhancer
0,329  0,013  Antiviral (Influenza A)
0,355  0,042  Cytotoxic
0,366  0,053  5 Hydroxytryptamine release stimulant
0,305  0,005  ABCA1 expression enhancer
0,318  0,020  Prostatic (benign) hyperplasia treatment
0,347  0,052  Analeptic
0,297  0,004  Potassium channel (Ca-activated) blocker
0,347  0,059  CYP2D6 substrate
0,346  0,058  AR expression inhibitor
0,345  0,067  Prostate cancer treatment
0,333  0,056  CYP1A2 substrate
0,287  0,010  Antineoplastic antibiotic
0,375  0,099  Calcium channel L-type activator
0,331  0,058  Lipoprotein disorders treatment
0,323  0,052  Antineoplastic (glioma)
0,282  0,013  UGT2B9 substrate
0,270  0,004  Antineoplastic alkaloid
0,403  0,137  Antiinflammatory
0,318  0,062  Antineoplastic (pancreatic cancer)
0,280  0,024  UGT1A3 substrate
0,328  0,073  ICAM1 expression inhibitor
0,290  0,037  UDP-glucuronosyltransferase substrate
0,272  0,022  UGT2B15 substrate
0,300  0,052  Cardiovascular analeptic
0,330  0,083  Transcription factor NF kappa B inhibitor
0,305  0,059  UGT1A9 substrate
0,252  0,008  Contraceptive female
0,288  0,047  Antineoplastic (sarcoma)
0,302  0,069  Antineoplastic (melanoma)
0,241  0,009  Contraceptive male
0,287  0,057  Antineoplastic (renal cancer)
0,283  0,054  Hypolipemic
0,234  0,010  Androgen antagonist
0,279  0,057  Cytostatic
0,315  0,096  Antileukemic
0,261  0,044  Abortion inducer
0,222  0,007  Pregnane X receptor agonist
0,263  0,049  Chemopreventive
0,222  0,009  Opioid kappa receptor antagonist
0,286  0,075  Antineoplastic (multiple myeloma)
0,221  0,011  Estrogen antagonist
0,253  0,043  Antialcoholic
0,266  0,057  Antineoplastic (glioblastoma multiforme)
0,273  0,064  NOS2 expression inhibitor
0,293  0,085  Antineoplastic (brain cancer)
0,222  0,016  Arachidonic acid antagonist
0,291  0,086  Hepatic disorders treatment
0,316  0,111  Antipruritic, allergic
0,227  0,026  VEGF expression inhibitor
0,205  0,009  Estrogen receptor beta antagonist
0,257  0,067  Angiogenesis stimulant
0,314  0,125  Antibacterial
0,192  0,005  Paget's disease treatment
0,225  0,041  Age-related macular degeneration treatment
0,186  0,002  Progesterone agonist
0,257  0,074  Teratogen
0,183  0,005  Ca(v)3.1 blocker
0,256  0,079  Transcription factor STAT3 inhibitor
0,229  0,052  Neurotrophic factor enhancer
0,281  0,104  Cholesterol antagonist
0,276  0,103  Apoptosis antagonist
0,247  0,074  Antiprotozoal (Leishmania)
0,237  0,065  Antimitotic
0,245  0,075  Antineoplastic (liver cancer)
0,174  0,004  Glycine receptor antagonist
0,172  0,004  Narcotic antagonist
0,207  0,040  Antiacne
0,217  0,050  Antipruritic, non-allergic
0,182  0,019  UGT2B1 substrate
0,241  0,077  Tyrosine 3 hydroxylase inhibitor
0,202  0,041  Toxic, respiratory center
0,241  0,082  Proliferative diseases treatment
0,196  0,040  UGT2B10 substrate
0,163  0,012  Anabolic
0,271  0,120  Antiprotozoal (Plasmodium)
0,177  0,031  Antifungal (Cryptococcus)
0,248  0,102  Hypoxia-inducible factor 1 alpha inhibitor
0,173  0,028  Microtubule formation inhibitor
0,169  0,028  Endometrios treatment
0,281  0,143  TNF expression inhibitor
0,163  0,029  SULT1A1 substrate
0,134  0,007  Acetyl-CoA transferase inhibitor
0,211  0,086  Cyclic AMP phosphodiesterase inhibitor
0,163  0,040  Farnesoid X receptor antagonist
0,211  0,087  Embryotoxic
0,197  0,074  Sedative
0,192  0,070  Hepatoprotectant
0,131  0,011  Na+ K+ transporting ATPase inhibitor
0,171  0,056  Interferon gamma antagonist
0,157  0,043  Protein-tyrosine phosphatase 1B inhibitor
0,180  0,067  Antirickettsial
0,139  0,029  Opioid antagonist
0,157  0,052  Adenylate cyclase stimulant
0,129  0,027  UGT2B11 substrate
0,108  0,014  GABA A receptor antagonist
0,199  0,105  Antihypercholesterolemic
0,155  0,062  Antineoplastic (squamous cell carcinoma)
0,107  0,014  GABA receptor antagonist
0,150  0,059  MAP3K9 inhibitor
0,095  0,005  Glucocorticoid antagonist
0,133  0,043  Choleretic
0,211  0,123  Transcription factor STAT inhibitor
0,194  0,109  RNA-directed DNA polymerase inhibitor
0,118  0,033  Actinic keratosis treatment
0,124  0,040  Toll-Like receptor 4 antagonist
0,101  0,017  Anticholelithogenic
0,110  0,028  Opioid mu receptor antagonist
0,097  0,016  Androgen agonist
0,154  0,074  Protein-tyrosine phosphatase inhibitor
0,122  0,044  Antiinfertility, female
0,084  0,008  RNA-directed RNA polymerase stimulant
0,106  0,029  Opioid delta receptor antagonist
0,192  0,116  Tumour necrosis factor alpha release inhibitor
0,166  0,094  P-glycoprotein inhibitor
0,131  0,061  DNA polymerase I inhibitor
0,083  0,014  Estrogen receptor beta agonist
0,153  0,085  Growth hormone agonist
0,087  0,020  Postmenopausal disorders treatment
0,220  0,154  Vasodilator, peripheral
0,229  0,164  Ulceration
0,143  0,080  Antidiarrheal
0,075  0,017  Lipocortins synthesis agonist
0,186  0,127  Antihypotensive
0,118  0,060  TRPA1 agonist
0,136  0,077  Antiparkinsonian, tremor relieving
0,115  0,058  GABA C receptor antagonist
0,078  0,023  Estrogen agonist
0,090  0,035  Estrogen receptor alpha antagonist
0,074  0,020  Heme oxygenase stimulant
0,153  0,100  Death-associated protein kinase 2 inhibitor
0,100  0,049  SULT1E1 substrate
0,066  0,016  Opioid kappa receptor agonist
0,157  0,107  Anesthetic general
0,232  0,182  Antiprotozoal
0,057  0,008  Glucose-6-phosphate dehydrogenase inhibitor
0,164  0,117  Antiparasitic
0,229  0,183  15-Lipoxygenase inhibitor
0,068  0,023  Postcoital contraceptive
0,066  0,021  Acetyl-CoA transferase 2 inhibitor
0,116  0,074  Growth stimulant
0,058  0,017  Liver X receptor agonist
0,188  0,148  Chemoprotective
0,211  0,171  Interleukin 2 agonist
0,134  0,096  Mutagenic
0,051  0,015  Hypogonadism treatment
0,134  0,099  Ca2+-transporting ATPase inhibitor
0,163  0,131  Antineoplastic enhancer
0,048  0,016  Farnesoid X receptor agonist
0,148  0,118  Psychostimulant
0,149  0,119  Interleukin antagonist
0,115  0,085  Tubulin antagonist
0,165  0,136  Antineoplastic (non-small cell lung cancer)
0,217  0,189  Calcium channel activator
0,065  0,038  Aromatase inhibitor
0,045  0,019  Estrogen receptor alpha agonist
0,107  0,081  Menstruation disorders treatment
0,091  0,066  Prolactin inhibitor
0,076  0,052  Analgesic, opioid
0,069  0,047  SULT2A1 substrate
0,050  0,030  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,103  0,084  Cholesterol synthesis inhibitor
0,049  0,031  Aldosterone antagonist
0,141  0,126  Phospholipase C inhibitor
0,091  0,076  Sulfotransferase substrate
0,047  0,032  Opioid mu receptor agonist
0,053  0,038  Nicotinic alpha3beta2 receptor antagonist
0,070  0,056  CDC25A inhibitor
0,019  0,005  Antibiotic Tetracycline-like
0,047  0,034  Mineralocorticoid receptor antagonist
0,057  0,045  Bombesin 1 receptor agonist
0,051  0,039  Opioid agonist
0,215  0,206  Antineoplastic (small cell lung cancer)
0,268  0,259  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,034  0,025  Tubulin agonist
0,104  0,096  Constipation treatment
0,035  0,028  5-Alpha-reductase inhibitor
0,043  0,037  Microtubule stabilization
0,114  0,109  Psychosexual dysfunction treatment
0,124  0,119  Carcinogenic
0,043  0,038  Parathyroid hormone antagonist
0,012  0,008  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,053  0,050  Pregnane X receptor antagonist
0,159  0,155  Antioxidant
0,104  0,102  Alcohol dehydrogenase substrate
0,117  0,115  Antiviral (Herpes)
0,024  0,023  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor

